Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterotoxigenic Escherichia coli (ETEC) antigens are the primary virulence factors of ETEC, the leading cause of bacterial diarrhea worldwide, particularly in children and travelers to endemic areas (Qadri et al., 2005, Clinical Microbiology Reviews). These antigens include heat-labile enterotoxin (LT), heat-stable enterotoxin (ST), and a variety of colonization factors (CFs), which are surface-expressed fimbriae or pili (Fleckenstein et al., 2010, Nature Reviews Microbiology). LT is an AB5-type toxin that increases intracellular cAMP levels, while ST is a small peptide that activates guanylate cyclase C to increase cGMP, both leading to chloride secretion and water loss in the intestine (Walker et al., 2015, Vaccine). Colonization factors facilitate the initial attachment of the bacteria to the intestinal mucosa, a prerequisite for colonization and subsequent toxin delivery. These antigens serve as the target for both prophylactic vaccines, such as the whole-cell inactivated ETVAX, and passive immunotherapies like hyperimmune bovine colostrum. Because the cholera toxin B-subunit is highly homologous to the ETEC LT B-subunit, certain oral cholera vaccines provide cross-protective immunity against LT-producing ETEC strains (Clemens et al., 2004, The Lancet).
Neutralization of LT and ST enterotoxins to prevent fluid secretion and blockade of colonization factors to inhibit bacterial adherence to the intestinal epithelium.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterotoxigenic Escherichia coli antigens (ETEC antigens).